Haematological Emergencies (Part 1) Ray Mun Koo Haematology Advanced Trainee Canberra Hospital

Size: px
Start display at page:

Download "Haematological Emergencies (Part 1) Ray Mun Koo Haematology Advanced Trainee Canberra Hospital"

Transcription

1 Haematological Emergencies (Part 1) Ray Mun Koo Haematology Advanced Trainee Canberra Hospital

2

3 Case Number 1 43 year old male presenting with fevers, abdominal distension and weight gain over 2 weeks. No past medical history of significance. Physical examination: Tense ascites CT-Abdo/Pelvis: Multiple enlarged para-aortic, mediastinal, mediastinal and epicardial lymph nodes. Abnormal thickening of jejunum

4

5 Other investigations PET-CT: Intense FDG avid lymph nodes above and below the diaphragm, with bone marrow involvement Bone marrow biopsy: 90% marrow infiltration with Burkitt s lymphoma FISH: MYC rearrangement detected

6

7 ?

8 Tumour Lysis Syndrome (TLS) Rapid breakdown of malignant tumour cells causing metabolic derangements Release of intracellular metabolites End-organ dysfunction Morbidity, mortality and increased length of stay!

9 TLS Pathogenesis

10 TLS Biochemical Manifestation Hyperkalaemia Hyperphosphataemia (Secondary) hypocalcaemia Hyperuricaemia Creatinine Lactate dehydrogenase

11 TLS Clinical Manifestation Nausea/vomitting Anorexia Lethargy Muscle cramps Signs of heart failure and renal failure Oliguria/anuria Death

12 TLS Definition Cairo-Bishop definition (2004) Laboratory TLS Clinical TLS Laboratory TLS + Creatinine, seizures, cardiac arrhythmias or sudden death

13 TLS Risk Factors Haematological malignancies High tumour cell proliferation rate Chemosensitive malignancies Large tumour burden High WCC (> 50) prior to treatment Examples: Burkitt s lymphoma, acute lymphoblastic leukaemia or acute myeloid leukaemia (with high WCC)

14 TLS Risk Factors Patient predisposition Baseline renal impairment Hyperuricaemia Dehydration or inadequate fluid resuscitation during treatment

15 TLS Risk Factors Non-Haematological malignancies (rare) Breast cancer SCLC Neuroblastoma Sarcoma

16 Spontaneous TLS Occurs prior to initiation of therapy. Burkitt s lymphoma, acute leukaemias and diffuse large B-cell lymphomas (DLBCL) with large tumour burden.

17 TLS Management Prevention is better than cure!

18 TLS Management (cont.) Pharmacological management Allopurinol Xanthine oxidase inhibitor 300mg daily (if Cr normal) 100mg daily (if renal impairment) Rasburicase Urate oxidase 6mg IV flat dose Risk of: Haemolysis in G6PD deficiency Anaphylaxis in repeat dosing

19 TLS Management (cont.) Intravenous fluid resuscitation Normal saline 1L over 8-10 hours Avoid Hartmann s solution Twice daily bloods UEC, CMP, LFT, LDH and uric acid LDH should be <60 Strict fluid balance monitoring No PUIT! Aim UO mls/hour

20 Allopurinol started on 10/6/17

21 Rasburicase given at 1700 hours Chemo started at 1200 hours Admitted to ICU for CRRT

22 Take home messages Prevention is better than cure. Consider TLS as a differential in Haem/Oncology patients with unexpected renal failure and dyselectrolytaemia If suspecting a Haematological diagnosis, always ask for Flow Cytometry.

23 Case Number 2 23 year old carpenter apprentice, transferred from peripheral hospital with undifferentiated septic shock to ICU. Complicated by: Anuric renal failure (Cr 426) Refractory hypotension Septic encephalopathy Type 1 respiratory failure - intubated Returned from Melbourne after celebrating NYE: Snorted cocaine with some mates 3 day history of fevers, rigors and headaches

24 Macular-papular rash appears

25

26 ?

27 Disseminated Intravascular Coagulation (DIC) Dynamic, procoagulant and pro-thrombotic state. Characterised by intravascular coagulation and fibrinolysis due to procoagulant exposure, with resultant end-organ damage.

28 Pathogenesis

29 Two types of DIC Acute DIC = Decompensated Significant generation of thrombin, rapid consumption of coagulation factors Therefore: Thrombocytopaenia Elevated PT and APTT Elevated XDP Bleeding > thrombosis Seen in: Sepsis Trauma Acute promyelocytic leukaemia (APML)

30 Two types of DIC (cont.) Chronic DIC = Compensated Therefore +/- Normal PT and APTT +/- Thrombocytopaenia Elevated XDP Thrombosis > Bleeding Seen in: Advanced malignancy Pancreas Primary brain Gastric Ovarian

31 Clinical manifestations Bleeding and thrombosis Organ dysfunction Laboratory abnormalities

32 Causes of DIC Sepsis Malignancy Trauma Obstetric complications Intravascular haemolysis

33 DIC mimics Chronic liver disease Heparin-induced thrombocytopaenia Thrombotic thrombocytopaenic purpura (TTP) Thrombotic microangiopathies Haemolytic uraemic syndrome Complement-mediated HUS

34 DIC Treatment Supportive Treat the sepsis Transfuse as required PRBCS if Hb < 70g/L Pooled platelets if Plts < 10 (with exceptions) Cryoprecipitate if fibrinogen < 1.0g/L Liberal FFP transfusion to correct coagulopathy not recommended (Cure the cancer)

35 Take home messages (2) Two types of DIC Suspect acute DIC in unexplained coagulopathy with thrombocytopaenia Chronic DIC is under-diagnosed, suspect in thromboembolism in certain malignancies Transfuse judiciously

36 Topics Tumour Lysis Syndrome Disseminated Intravascular Coagulation Hyperviscosity Syndrome Hyperleukocytosis Hypercalcaemia? Febrile Neutropaenia? Other topics (JMO driven)

GUIDELINE FOR THE MANAGEMENT AND PREVENTION OF ACUTE TUMOUR LYSIS SYNDROME IN HAEMATOLOGICAL MALIGNANCIES

GUIDELINE FOR THE MANAGEMENT AND PREVENTION OF ACUTE TUMOUR LYSIS SYNDROME IN HAEMATOLOGICAL MALIGNANCIES GUIDELINE FOR THE MANAGEMENT AND PREVENTION OF ACUTE TUMOUR LYSIS SYNDROME IN HAEMATOLOGICAL MALIGNANCIES Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Abdominal tumors, in children, 530 531 Alkalinization, in tumor lysis syndrome, 516 Allopurinol, in tumor lysis syndrome, 515 Anaphylaxis, drug

More information

2.1 mmol/l or 25% increase from baseline mmol/l or 25% decrease from baseline

2.1 mmol/l or 25% increase from baseline mmol/l or 25% decrease from baseline 22.1 Hyperleukocytosis and tumour lysis syndrome The guideline is addressed for ALL patients with hyperleukocytosis (WBC 100 x109/l) only and should not be used without modifications in case of other diseases

More information

Transfusion Requirements and Management in Trauma RACHEL JACK

Transfusion Requirements and Management in Trauma RACHEL JACK Transfusion Requirements and Management in Trauma RACHEL JACK Overview Haemostatic resuscitation Massive Transfusion Protocol Overview of NBA research guidelines Haemostatic resuscitation Permissive hypotension

More information

Maresce Bizaare AWACC 2013

Maresce Bizaare AWACC 2013 Maresce Bizaare AWACC 2013 Cytopaenias in HIV Most common complication of HIV Anaemia is most common cytopaenia ITP occurs in 30%, may be first manifestation of HIV Laboratory approach to cytopaenia FBC,

More information

Approach to disseminated intravascular coagulation

Approach to disseminated intravascular coagulation Approach to disseminated intravascular coagulation Khaire Ananta Shankarrao 1, Anil Burley 2, Deshmukh 3 1.MD Scholar, [kayachikitsa] 2.Professor,MD kayachikitsa. 3.Professor and HOD,Kayachikitsa. CSMSS

More information

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC Things to never miss in the office Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC Presenter Disclosure Faculty / Speaker s name: Brett Houston / Leonard Minuk Relationships with commercial

More information

Blood is serious business

Blood is serious business Transfusion at RCH BLOOD TRANSFUSION Anthea Greenway Dept of Clinical Haematology >10000 fresh blood products per year Supports craniofacial and cardiac surgery Support bone marrow, liver transplant and

More information

Managing patients with bulky cancers

Managing patients with bulky cancers SIOP PODC Supportive Care Education (ICON 2016) Presentation Date: 23 rd January 2016 Recording Link at www.cure4kids.org: https://www.cure4kids.org/ums/home/conference_rooms/enter.php?room=p2pjfjp8nha

More information

Guidelines for use of RASBURICASE in adult Haematology and Oncology patients

Guidelines for use of RASBURICASE in adult Haematology and Oncology patients Network Guidance Document Guidelines for use of RASBURICASE in adult Haematology and Oncology patients Status: Expiry Date: Version Number: Publication Date: Final September 2013 6 September 2011 Page

More information

Transfusion Challenges. - Transfusion Reactions - Do they need platelets? Dr. Eoghan Molloy Haem SpR 2016

Transfusion Challenges. - Transfusion Reactions - Do they need platelets? Dr. Eoghan Molloy Haem SpR 2016 Transfusion Challenges - Transfusion Reactions - Do they need platelets? Dr. Eoghan Molloy Haem SpR 2016 Guidance on Transfusion Hospital transfusion guidelines and procedures Irish Blood Transfusion Service

More information

Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department

Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department Disseminated intravascular coagulation (DIC, consumptive coagulopathy) is a clinicopathologic

More information

M5 MEQs /10/2016 Case 3: Ms Hui Bo Gao

M5 MEQs /10/2016 Case 3: Ms Hui Bo Gao M5 MEQs 2016 01/10/2016 Case 3: Ms Hui Bo Gao http://tinyurl.com/jst7stf Welcome to the amazing world of hematology J Question 1.1: Ms Hui Bo Gao Ms Hui is a 30 years old female. She has no past medical

More information

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH Cytopaenias in HIV Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH Introduction Cytopaenias in HIV are common Anaemias multifactorial causes Thrombocytopaenias may be the first

More information

Hematologic Emergency. Le Wang, MD, PhD Hematology & Oncology

Hematologic Emergency. Le Wang, MD, PhD Hematology & Oncology Hematologic Emergency Le Wang, MD, PhD Hematology & Oncology Severe Thrombocytopenia (ITP) Clinical: bleeding risk 0 no bleeding; 1 minimal bleeding after trauma; 2 spontaneous but selflimited bleeding;

More information

Spontaneous Tumor Lysis Syndrome in Small Cell Lung Cancer

Spontaneous Tumor Lysis Syndrome in Small Cell Lung Cancer Open Access Case Report DOI: 10.7759/cureus.1017 Spontaneous Tumor Lysis Syndrome in Small Cell Lung Cancer Venkatkiran Kanchustambham 1, Swetha Saladi 2, Setu Patolia 2, David Stoeckel 2 1. Pulmonary

More information

DIC. Bert Vandewiele Fellow Critical Care 23 May 2011

DIC. Bert Vandewiele Fellow Critical Care 23 May 2011 DIC Bert Vandewiele Fellow Critical Care 23 May 2011 Dissiminated Intravascular Coagulopathie 11/3/2011 Dr. Bert Vandewiele 2 Dissiminated Intravascular Coagulopathie = Consumption coagulopathie = Defibrination

More information

Heme (Bleeding and Coagulopathies) in the ICU

Heme (Bleeding and Coagulopathies) in the ICU Heme (Bleeding and Coagulopathies) in the ICU General Topics To Discuss Transfusions DIC Thrombocytopenia Liver and renal disease related bleeding Lack of evidence in managing critical illness related

More information

Clinical & Laboratory Assessment

Clinical & Laboratory Assessment Clinical & Laboratory Assessment Dr Roger Pool NHLS & University of Pretoria Clinical Assessment (History) Anaemia ( haemoglobin) Dyspnoea (shortness of breath) Tiredness Angina Headache Clinical Assessment

More information

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne Overview of coagulation Testing coagulation Coagulopathy in ICU Incidence Causes Evaluation Management Coagulation

More information

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College Leukemias Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College Introduction Leukaemias are malignant disorders of the haematopoietic stem cell compartment,

More information

DERBY-BURTON CANCER NETWORK CONTROLLED DOC NO:

DERBY-BURTON CANCER NETWORK CONTROLLED DOC NO: OBINUTUZUMAB+CHLORAMBUCIL Regimen RDH; Day 1 and 2 Dose to be given on Ward Available for Routine Use in Burton in-patient Derby in-patient Burton day-case Derby day-case Burton community Derby community

More information

DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL

DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL DR V PHILIP CLINICAL HAEMATOLOGY UNIT CHRIS HANI BARAGWANATH ACADEMIC HOSPITAL Rare but fatal disease if unrecognized and untreated Incidence about 1: 1 million in the USA Female preponderance of 2:1 Part

More information

Contents Page No. 1. Outline of Procedure 2. Area of Application 3. Objective 4. Stages of the Process 5. Responsibilities

Contents Page No. 1. Outline of Procedure 2. Area of Application 3. Objective 4. Stages of the Process 5. Responsibilities Contents Page No. 1. Outline of Procedure 3 2. Area of Application 3 3. Objective 3 4. Stages of the Process 3 5. Responsibilities 8 6. Other useful information 8 7. References 8 Page 2 of 10 Clinical

More information

Non-immune acquired haemolytic anaemias. Dr.Maysem

Non-immune acquired haemolytic anaemias. Dr.Maysem Non-immune acquired haemolytic anaemias Dr.Maysem Causes of Non-immune acquired haemolytic anaemias. Infections Infections can cause haemolysis in a variety of ways: -They may precipitate an acute haemolytic

More information

Laboratory Empowerment. Debbie Asher Adrian Ebbs Transfusion Laboratory Managers, Eastern Pathology Alliance

Laboratory Empowerment. Debbie Asher Adrian Ebbs Transfusion Laboratory Managers, Eastern Pathology Alliance Laboratory Empowerment Debbie Asher Adrian Ebbs Transfusion Laboratory Managers, Eastern Pathology Alliance Why? Electronic ICE requesting was in use for requesting red cells NBTC Indication Codes were

More information

Contents. Contributors. Reviewers. Acknowledgements I CARDIOVASCULAR COMPLICATIONS

Contents. Contributors. Reviewers. Acknowledgements I CARDIOVASCULAR COMPLICATIONS Contributors Reviewers Acknowledgements Preface xii xvi xvii xviii I CARDIOVASCULAR COMPLICATIONS 1 Cardiac Complications of Cancer and Anticancer Treatment 3 Introduction 3 Malignant Pericardial Effusion

More information

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University

LEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University LEUKAEMIA and LYMPHOMA Dr Mubarak Abdelrahman Assistant Professor Jazan University OBJECTIVES Identify etiology and epidemiology for leukemia and lymphoma. Discuss common types of leukemia. Distinguish

More information

TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006

TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 CTU blood product transfusion guidelines 2006 1 Summary of guidelines RED CELLS (10-15ml/kg) This applies to ward patients / icu patients who are stable.

More information

Oncology Emergency Essentials: Addressing Tumor Lysis Syndrome in Your Practice

Oncology Emergency Essentials: Addressing Tumor Lysis Syndrome in Your Practice Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Acute lung injury (ALI) transfusion-related, 363 372. See also Transfusion-related acute lung injury (TRALI) ALI. See Acute lung injury

More information

What is meant by Thrombotic Microangiopathy (TMA)?

What is meant by Thrombotic Microangiopathy (TMA)? What is meant by Thrombotic Microangiopathy (TMA)? Thrombotic Microangiopathy (TMA) is a group of disorders characterized by injured endothelial cells, microangiopathic hemolytic anemia (MAHA), with its

More information

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE CONTENTS Definition Indications Transfusion trigger Massive transfusion protocol Complications DEFINITION Massive transfusion:

More information

Outcome of Tumor Lysis Syndrome with Hydration and Alkalinization in Children with Acute Lymphoblastic Leukemia

Outcome of Tumor Lysis Syndrome with Hydration and Alkalinization in Children with Acute Lymphoblastic Leukemia Bangladesh Journal of Medical Science Vol. 11 No. 04 Oct 12 Original article Outcome of Tumor Lysis Syndrome with Hydration and Alkalinization in Children with Acute Lymphoblastic Leukemia Sultana A 1,

More information

4100: Cellular Therapy Essential Data Follow-Up Form

4100: Cellular Therapy Essential Data Follow-Up Form 4100: Cellular Therapy Essential Data Follow-Up Form Registry Use Only Sequence Number: Date Received: Key Fields CIBMTR Center Number: Event date: Visit: 100 day 6 months 1 year 2 years >2 years, Specify:

More information

ACQUIRED COAGULATION ABNORMALITIES

ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES - causes 1. Liver disease 2. Vitamin K deficiency 3. Increased consumption of the clotting factors (disseminated intravascular coagulation

More information

Index. Note: Page numbers of article numbers are in boldface type.

Index. Note: Page numbers of article numbers are in boldface type. Index Note: Page numbers of article numbers are in boldface type. A Abdomen, acute, as cancer emergency, 381 399 in cancer patients, etiologies unique to, 390 392 in perforation, 388 surgery of, portal

More information

Part 1 examination. Haematology: First paper. Tuesday 20 March Candidates must answer all questions. Each question is worth a total of 25 marks.

Part 1 examination. Haematology: First paper. Tuesday 20 March Candidates must answer all questions. Each question is worth a total of 25 marks. Part 1 examination Haematology: First paper Tuesday 20 March 2018 Candidates must answer all questions. Each question is worth a total of 25 marks. Time allowed: 3 hours Question 1: General Haematology

More information

Assessing thrombocytopenia in the intensive care unit: The past, present, and future

Assessing thrombocytopenia in the intensive care unit: The past, present, and future Assessing thrombocytopenia in the intensive care unit: The past, present, and future Ryan Zarychanski MD MSc FRCPC Sections of Critical Care and of Hematology, University of Manitoba Disclosures FINANCIAL

More information

Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusion.

Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusion. 1. NAME OF THE MEDICINAL PRODUCT Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION After reconstitution, 1 ml of Fasturtec concentrate

More information

Risk Evaluation and Mitigation Strategy (REMS): Cytokine release syndrome and neurological toxicities

Risk Evaluation and Mitigation Strategy (REMS): Cytokine release syndrome and neurological toxicities Risk Evaluation and Mitigation Strategy (REMS): Cytokine release syndrome and neurological toxicities A REMS is a program required by the FDA to manage known or potential serious risks associated with

More information

CCM Specialty Board Tutorial. Dr. Herman Liu Department of Medicine PYNEH 17 Dec 2013

CCM Specialty Board Tutorial. Dr. Herman Liu Department of Medicine PYNEH 17 Dec 2013 CCM Specialty Board Tutorial Dr. Herman Liu Department of Medicine PYNEH 17 Dec 2013 Case 1 Case 1 F/30 Good past health Gum bleeding CBC: Hb 12.1 MCV 95.0 platelet 35 WBC 9.3 Promyelocyte 4.1 blast2.3

More information

Obinutuzumab+Bendamustine followed by Obinutuzumab Maintenance Burton in-patient Derby in-patient Burton day-case Derby day-case

Obinutuzumab+Bendamustine followed by Obinutuzumab Maintenance Burton in-patient Derby in-patient Burton day-case Derby day-case Obinutuzumab+Bendamustine followed by Obinutuzumab Maintenance Burton in-patient Derby in-patient Burton day-case Derby day-case Burton community Derby community Burton out-patient Derby out-patient Available

More information

Effect of under filling tube

Effect of under filling tube Effect of under filling tube 2 What constitutes underfilling? A 4.5ml vacutainer collection tube should contain at least 4ml of blood Less than that could give falsely prolonged clotting times ALSO be

More information

Tumour Lysis Syndrome (TLS)

Tumour Lysis Syndrome (TLS) (TLS) Overview: Tumour lysis syndrome refers to a number of metabolic disturbances (hyperuricaemia, hyperphosphataemia, hyperkalaemia and hypocalcaemia) that occur as the result of rapid cell lysis. This

More information

HAEMATOLOGICAL MALIGNANCY

HAEMATOLOGICAL MALIGNANCY HAEMATOLOGICAL MALIGNANCY Reference Compulsory reading Haematology at Glance 2 nd ed. Atul Mehta & Victor Hoffbrand Chapters: 20 to 31 Pages: 46 to 69 Pathogenesis of Haematological Malignancy Figure (a)

More information

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests Minor Allergic (Urticarial) Urticaria, pruritis, flushing, rash If skin reaction only and mild hives/ rash

More information

Part 1 examination. Haematology: First paper. Tuesday 25 September 2018

Part 1 examination. Haematology: First paper. Tuesday 25 September 2018 Part 1 examination Haematology: First paper Tuesday 25 September 2018 Candidates must answer all questions. Each question is worth a total of 25 marks. Time allowed: 3 hours 1. Haemato-oncology. A 22 year

More information

A 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch

A 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch A 60 year old woman with altered mental status and thrombotic microangiopathy Josh Veatch Previously healthy 60 year old woman 2 3 months of fatigue following a URI, transient episodes being out of it

More information

Thrombotic Microangiopathies

Thrombotic Microangiopathies Thrombotic Microangiopathies ASH/San Antonio Breast Cancer Symposium Review James N. George March 14, 2015 Thrombotic Microangiopathies (TMA): Everything you need to know from 5 patient stories Thrombotic

More information

GOOD MORNING! July 3, 2014

GOOD MORNING! July 3, 2014 GOOD MORNING! July 3, 2014 OUR PATIENT 4yo Female with: 2 days of fever, sore throat, swollen nodes in neck and abdominal pain PMH: Tonsillectomy age 2 Immunizations: UTD NKDA DIFFERENTIAL: OUR PATIENT

More information

Renal failure and thrombocytopaenia? Don t forget TTP/HUS. Jonathan Wala Nephrologist

Renal failure and thrombocytopaenia? Don t forget TTP/HUS. Jonathan Wala Nephrologist Renal failure and thrombocytopaenia? Don t forget TTP/HUS Jonathan Wala Nephrologist Thrombotic microangiopathies Disorders characterized by: thrombocytopaenia microangiopathic haemolytic anaemia (MAHA)

More information

Tretinoin - ATRA (All Trans Retinoic Acid)

Tretinoin - ATRA (All Trans Retinoic Acid) Tretinoin - ATRA (All Trans Retinoic Acid) Indication Treatment of acute promyelocytic leukaemia (APML) Used in combination with chemotherapy. ICD-10 codes C92.4 Regimen details APML induction therapy

More information

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion?

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion? Blood Components and Transfusions Describe blood components Identify nursing responsibilities r/t blood transfusion Discuss factors r/t blood transfusion including blood typing, Rh factor, and cross matching

More information

MANAGEMENT OF DENGUE INFECTION IN ADULTS (Revised 2 nd Edition) QUICK REFERENCE FOR HEALTHCARE PROVIDERS

MANAGEMENT OF DENGUE INFECTION IN ADULTS (Revised 2 nd Edition) QUICK REFERENCE FOR HEALTHCARE PROVIDERS 1 KEY MESSAGES Dengue is a dynamic disease and presented in three phases - febrile phase, critical phase and recovery phase. Clinical deterioration often occurs in the critical phase and is marked by plasma

More information

Major Haemorrhage Protocol. Commentary

Major Haemorrhage Protocol. Commentary Hairmyres Hospital Monklands Hospital Wishaw General Hospital Major Haemorrhage Protocol Commentary N.B. There is a separate NHSL protocol for the Management of Obstetric Haemorrhage Authors Dr Tracey

More information

EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION

EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE

More information

Transfusion reactions. Jim Taylor Haematology SpR Sheffield

Transfusion reactions. Jim Taylor Haematology SpR Sheffield Transfusion reactions Jim Taylor Haematology SpR Sheffield Pre questions 1. Platelet transfusions are more prone to bacterial contamination compared to red cells. T/F 2. Common causes of an acute transfusion

More information

Easy Trick to Spot Leukemia for Pediatricians

Easy Trick to Spot Leukemia for Pediatricians Easy Trick to Spot Leukemia for Pediatricians Piya Rujkijyanont, MD Division of Hematology-Oncology Department of Pediatrics Phramongkutklao Hospital Most Common Pediatric Cancers Age 0-14 Leukemia 32%

More information

THERAPEUTIC PLASMA EXCHANGE

THERAPEUTIC PLASMA EXCHANGE THERAPEUTIC PLASMA EXCHANGE DIRECTORATE OF NEPHROLOGY AND TRANSPLANTATION Background and Indications Therapeutic plasma exchange (TPE) is an extracorporeal blood purification technique in which plasma

More information

Therapeutic Leukocyte Reduction (TLR) For Myeloid Leukaemia's : A Four Year Experience From An Oncology Centre In India

Therapeutic Leukocyte Reduction (TLR) For Myeloid Leukaemia's : A Four Year Experience From An Oncology Centre In India Therapeutic Leukocyte Reduction (TLR) For Myeloid Leukaemia's : A Four Year Experience From An Oncology Centre In India Anita Tendulkar, Jain P, Gupta A, Sharma N, Navkudkar A, Patle V Dr Anita Tendulkar

More information

HEME 10 Bleeding Disorders

HEME 10 Bleeding Disorders HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional

More information

Transfusion-Related Acute Lung Injury (TRALI) and Strategies for Prevention. Khalid Abdulla Sharif, MD, MRCP (UK)*

Transfusion-Related Acute Lung Injury (TRALI) and Strategies for Prevention. Khalid Abdulla Sharif, MD, MRCP (UK)* Bahrain Medical Bulletin, Vol. 29, No.4, December 2007 Transfusion-Related Acute Lung Injury (TRALI) and Strategies for Prevention Khalid Abdulla Sharif, MD, MRCP (UK)* Background: Transfusion-Related

More information

Chapter 5: Sepsis Stephen Lo

Chapter 5: Sepsis Stephen Lo Chapter 5: Sepsis Stephen Lo Introduction Sepsis and its consequence are the bread and butter of intensive care medicine and management of it is time critical. This chapter will discuss the definitions,

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Abdominal radiotherapy, toxic effects of, 636 637 Acute promyelocytic leukemia, associated with acquired bleeding problems, 614 615 Acute renal

More information

Adult Acute leukemia. Matthew Seftel. August

Adult Acute leukemia. Matthew Seftel. August Adult Acute leukemia Matthew Seftel August 21 2007 mseftel@cancercare.mb.ca Principles 3 cases Diagnosis and classification of acute leukemia (AL) Therapy Emergencies Remission induction BMT Complications

More information

Development of tumor lysis syndrome (TLS): A potential risk factor in cancer patients receiving anticancer therapy

Development of tumor lysis syndrome (TLS): A potential risk factor in cancer patients receiving anticancer therapy www.bioinformation.net Hypothesis Volume 10(11) Development of tumor lysis syndrome (TLS): A potential risk factor in cancer patients receiving anticancer therapy Mahmood Rasool 1 *, Arif Malik 2, Muhammad

More information

DISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital

DISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital DISSEMINATED INTRAVASCULAR COAGULATION (DIC) Pichika Chantrathammachart MD Division of Hematology, Department of Medicine Ramathibodi Hospital Disseminated intravascular coagulation (DIC) Disseminated

More information

Managing Coagulopathy in Intensive Care Setting

Managing Coagulopathy in Intensive Care Setting Managing Coagulopathy in Intensive Care Setting Dr Rock LEUNG Associate Consultant Division of Haematology, Department of Pathology & Clinical Biochemistry Queen Mary Hospital Normal Haemostasis Primary

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Accelerated intravascular coagulation and fibrinolysis (AICF) in liver disease, 390 391 Acid suppression in liver disease, 403 404 ACLF.

More information

COMPLICATIONS OF BLOOD TRANSFUSIONS. :Prepared by Dr. Nawal Mogales & Dr. Mohammed Aqlan

COMPLICATIONS OF BLOOD TRANSFUSIONS. :Prepared by Dr. Nawal Mogales & Dr. Mohammed Aqlan COMPLICATIONS OF BLOOD TRANSFUSIONS :Prepared by Dr. Nawal Mogales & Dr. Mohammed Aqlan COMPLICATIONS OF TRANSFUSIONS Transfusion reaction may result from either : A. Immune transfusion reaction. B. Non

More information

PLASMA EXCHANGE J MANION NEPEAN HOSPITAL

PLASMA EXCHANGE J MANION NEPEAN HOSPITAL PLASMA EXCHANGE J MANION NEPEAN HOSPITAL PLASMA The fluid portion of blood Normally approx 5% body weight or 3.5L in 70kg male Clots on standing unless anticoagulated Common plasma proteins are albumin,

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdomen, acute, in oncological surgery patients, critical care issues in, 101 102 Acquired factor VIII inhibitors, in critically ill cancer

More information

Thursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III

Thursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III REGULATION OF COAGULATION Introduction HEMOSTASIS/THROMBOSIS III Regulation of Coagulation/Disseminated Coagulation necessary for maintenance of vascular integrity Enough fibrinogen to clot all vessels

More information

Haematological Cancer Suspected (Adults & Children)

Haematological Cancer Suspected (Adults & Children) Haematological Cancer Suspected (Adults & Children) Link to NICE guidelines: https://www.nice.org.uk/guidance/ng47 Patient of any age presents with symptoms of possible haematological cancer If 60 years

More information

NCCP Chemotherapy Regimen. Tretinoin (ATRA)/Idarubicin (PETHEMA AIDA) Induction Therapy

NCCP Chemotherapy Regimen. Tretinoin (ATRA)/Idarubicin (PETHEMA AIDA) Induction Therapy Tretinoin INDICATIONS FOR USE: Regimen Code 00366a *Reimbursement Indicator INDICATION ICD10 Treatment of patients with newly diagnosed Acute C92 Promyelocytic Leukaemia (APL) *If a reimbursement indicator

More information

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature) 1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory

More information

Risk Evaluation and Mitigation Strategy (REMS): Cytokine release syndrome and neurological toxicities

Risk Evaluation and Mitigation Strategy (REMS): Cytokine release syndrome and neurological toxicities Risk Evaluation and Mitigation Strategy (REMS): Cytokine release syndrome and neurological toxicities A REMS is a program required by the FDA to manage known or potential serious risks associated with

More information

Cancer in Children. Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine

Cancer in Children. Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine Cancer in Children Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine 07976 608871 anant.sachdev@nhs.net Aim of this very short session! Facts and figures relating to Childrens Cancers

More information

ULYRICE. Protocol Code. Lymphoma. Tumour Group. Dr. Laurie Sehn. Contact Physician

ULYRICE. Protocol Code. Lymphoma. Tumour Group. Dr. Laurie Sehn. Contact Physician BCCA Protocol Summary for the Treatment of Relapsed or Refractory Advanced Stage Aggressive B-Cell Non-Hodgkin s Lymphoma with Ifosfamide, CARBOplatin, Etoposide and rituximab Protocol Code Tumour Group

More information

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate Approach to bleeding disorders &treatment by RAJESH.N General medicine post graduate 2 Approach to a patient of bleeding diathesis 1. Clinical evaluation: History, Clinical features 2. Laboratory approach:

More information

CHEMOTHERAPY PROTOCOL FOR ADMINISTRATION OF VENETOCLAX

CHEMOTHERAPY PROTOCOL FOR ADMINISTRATION OF VENETOCLAX CHEMOTHERAPY PROTOCOL FOR ADMINISTRATION OF VENETOCLAX Therapeutic Indications: Venetoclax monotherapy is indicated for the treatment of chronic lymphocytic leukaemia (CLL) in the presence of 17p deletion

More information

MANAGEMENT OF COMMON BLEEDING DISORDERS. Auro Viswabandya Department of Haematology, CMC, Vellore

MANAGEMENT OF COMMON BLEEDING DISORDERS. Auro Viswabandya Department of Haematology, CMC, Vellore MANAGEMENT OF COMMON BLEEDING DISORDERS Auro Viswabandya Department of Haematology, CMC, Vellore BLOOD CLOT : PRIMARY HAEMOSTASIS (Platelets) + SECONDARY HAEMOSTASIS (Coagulation Factors) HAEMOSTATIC DISORDERS

More information

Guidelines for the Prevention of Tumour Lysis Syndrome

Guidelines for the Prevention of Tumour Lysis Syndrome 1.0 Introduction For the purposes of this guideline, tumour lysis syndrome (TLS) is defined as metabolic derangement resulting from abrupt and massive breakdown of malignant cells and the release of intracellular

More information

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate

More information

Disseminated Intravascular Coagulation (DIC) Seminar. Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.

Disseminated Intravascular Coagulation (DIC) Seminar. Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3. Disseminated Intravascular Coagulation (DIC) Seminar Ron Kopilov 4 th year Medical Student, Tel Aviv University Internal Medicine A 8.3.2012 1 Our plan: Understand the pathophysiology Identify risk factors

More information

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO. LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA 1011.02 Transfusion Criteria Version#2 Department POLICY NO. PAGE NO. Blood Bank Quality Assurance Manual

More information

Hematology Review. CCRN exam. The Coagulation Cascade. The Coagulation Cascade. Components include: Intrinsic pathway Extrinsic pathway Common pathway

Hematology Review. CCRN exam. The Coagulation Cascade. The Coagulation Cascade. Components include: Intrinsic pathway Extrinsic pathway Common pathway CCRN exam Hematology Review CCRN Review October 2013 Department of Critical Care Nursing Hematology is 2% of the exam Focus on coagulation cascade, DIC, and HIT Anatomy of the hematologic system Bone marrow

More information

NCCP Chemotherapy Regimen. Tretinoin (ATRA)/IDArubicin (PETHEMA AIDA) Induction Therapy: High Risk

NCCP Chemotherapy Regimen. Tretinoin (ATRA)/IDArubicin (PETHEMA AIDA) Induction Therapy: High Risk Tretinoin : High Risk INDICATIONS FOR USE: INDICATION ICD10 Regimen Code *Reimbursement Status Treatment of patients with newly diagnosed high risk Acute Promyelocytic Leukaemia (APL) C92 00366a Hospital

More information

Blood Transfusion Guidelines in Clinical Practice

Blood Transfusion Guidelines in Clinical Practice Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi

More information

Rasburicase 1.5 mg/ml powder and solvent for concentrate for solution for infusion. FASTURTEC

Rasburicase 1.5 mg/ml powder and solvent for concentrate for solution for infusion. FASTURTEC For the use only of a Registered Medical Practitioner or a Hospital or a Laboratory This package insert is continually updated. Please read carefully before using a new pack. Rasburicase 1.5 mg/ml powder

More information

Rip roaring hematologic dysfunction from solid organ malignancies

Rip roaring hematologic dysfunction from solid organ malignancies Rip roaring hematologic dysfunction from solid organ malignancies A tale from UWMC hematology consult service in 4/2017 Lindsay Hannan, MD MSPH Discussant: Dr. Sioban Keel. Main objectives 1) DIC scoring

More information

POLICY NO. Printed copies are for reference only. Please refer to the electronic copy for the latest version.

POLICY NO. Printed copies are for reference only. Please refer to the electronic copy for the latest version. Department Blood Bank POLICY NO. 4633 Department Of Pathology LBH Transfusion Criteria Version# 2 PAGE NO. 1 OF 9 Printed copies are for reference only. Please refer to the electronic copy for the latest

More information

Princess Alexandra Hospital Emergency Department. Clinical Module. Clinical features of envenoming: Major toxin syndromes 1 :

Princess Alexandra Hospital Emergency Department. Clinical Module. Clinical features of envenoming: Major toxin syndromes 1 : Princess Alexandra Hospital Emergency Department Clinical Module Toxicology Review Officer: Toxicology registrar Version no: 1 Approval date: February 2017 Review date: February 2019 Approving Officer

More information

Coagulation, Haemostasis and interpretation of Coagulation tests

Coagulation, Haemostasis and interpretation of Coagulation tests Coagulation, Haemostasis and interpretation of Coagulation tests Learning Outcomes Indicate the normal ranges for routine clotting screen and explain what each measurement means Recognise how to detect

More information

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Regional Paediatric Specialty Trainees teaching 4 th July 2017 Scope

More information

BLEEDING DISORDERS Simple complement:

BLEEDING DISORDERS Simple complement: BLEEDING DISORDERS Simple complement: 1. Select the statement that describe the thrombocytopenia definition: A. Marked decrease of the Von Willebrandt factor B. Absence of antihemophilic factor A C. Disorder

More information

The Bleeding Patient. Sarah Stacey Charlotte Maxeke Johannesburg Hospital University of the Witwatersrand

The Bleeding Patient. Sarah Stacey Charlotte Maxeke Johannesburg Hospital University of the Witwatersrand The Bleeding Patient Sarah Stacey Charlotte Maxeke Johannesburg Hospital University of the Witwatersrand The Bleeding Patient If you prick us, do we not bleed? Disorders of secondary homeostasis: dysfunction

More information

COAGULATION PROFILE AND ANALYSIS OF OUTCOME OF BLOOD COMPONENT THERAPY IN SNAKE BITE VICTIMS

COAGULATION PROFILE AND ANALYSIS OF OUTCOME OF BLOOD COMPONENT THERAPY IN SNAKE BITE VICTIMS COAGULATION PROFILE AND ANALYSIS OF OUTCOME OF BLOOD COMPONENT THERAPY IN SNAKE BITE VICTIMS Dr Aboobacker Mohamed Rafi 1, Dr Susheela J Innah Senior Resident Department of Transfusion Medicine Jubilee

More information

Contents SECTION 1: PHYSIOLOGY OF BLOOD

Contents SECTION 1: PHYSIOLOGY OF BLOOD Contents SECTION 1: PHYSIOLOGY OF BLOOD Chapter 1: Overview of Physiology of Blood 1 Normal Haematopoiesis 1 Red Blood Cells 6 White Blood Cells 15 Immune System 27 Megakaryopoiesis 32 Normal Haemostasis

More information